Flushing

 

What is flushing?

Flushing is a temporary redness of the face and neck. It may also be accompanied by a warm feeling.

What causes flushing?

Flushing is caused by a dilation, or opening, of the blood vessels in the face. This brings more blood to the surface of the skin. The body uses this mechanism to “let off” heat because the blood is warm and the extra heat is released into the cooler, outside environment. Alcohol and drugs, including some chemotherapy drugs, cause flushing. Menopause, some hormonal treatments such as tamoxifen, a class of drugs called aromatase inhibitors (Aromasin® [exemestane], Femara® [letrozole] , and Arimidex® [anastrozole]), and LHRH-A drugs frequently used to treat prostate cancer also can cause flushing and sweating.

What is the treatment for flushing?

The treatment for flushing depends upon the cause. Be sure to tell your doctor of any side effects that cause you concern. Medications in the antidepressant class, such as Effexor-XR® (venlafaxine) and the SSRI’s (Prozac® (fluoxetine), etc.), can help alleviate the symptom if it is hormone related as discussed above.

This content was last modified on January 10, 2008 .
Latest Cancer News
ACOG Updates Cervical Cancer Screening Guidelines

November 20, 2009 — The American College of Obstetricians and Gynecologists (ACOG) has revised its cervical cancer screening recommendations: the organization now recommends that women begin screening at the age of 21 and receive screening at less frequent intervals. These recommendations will be published in the December 2009 issue of Obstetrics and Gynecology.

New Velcade®-melphalan Transplant Regimen for Multiple Myeloma

November 20, 2009 — Researchers from France have reported encouraging results with adding Velcade® (bortezomib) to high-dose melphalan followed by autologus stem cell infusion for initial treatment of patients with newly diagnosed multiple myeloma. The details of this Phase II study appeared in an early online publication in Blood on November 2, 2009.

Folic Acid May Be Beneficial in Patients with Recurrent Colorectal Adenoma Who Are Folate Deficient

November 20, 2009 — Researchers affiliated with the Health Professional Follow-Up Study and the Nurses’ Health Study have reported that folic acid supplementation in patients with recurrent colorectal adenoma was not protective or harmful in most patients. However, patients who were folate deficient had a significant 39% decrease in adenoma recurrence. The details of this study appeared in an early online publication on October 28, 2009 in the American Journal of Clinical Nutrition.

Select news items provided by Reuters Health